EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of hypoxia‐inducible factors suppresses subretinal fibrosis

Chiho Shoda, Deokho Lee iD, Yukihiro Miwa iD, Satoru Yamagami iD, Hiroyuki Nakashizuka iD, Kazumi Nimura, Kazutoshi Okamoto, Hirokazu Kawagishi iD, Kazuno Negishi iD, Toshihide Kurihara iD

The FASEB Journal · 15.07.2024 · 38 (13)

DOI: 10.1096/fj.202400540rrr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 02.07.2024. Verfasst von Chiho Shoda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Photobiology, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Fibrosis, Retinal Pigment Epithelium, Von Hippel-Lindau Tumor Suppressor Protein, Mice, Knockout. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KAKENHI, Development of Research Seeds Based on Marine Biotechnology from Shizuoka Prefecture, JST SPRING.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Age‐related macular degeneration (AMD) is a common cause of vision loss. The aggressive form of AMD is associated with ocular neovascularization and subretinal fibrosis, representing a responsive outcome against neovascularization mediated by epithelial–mesenchymal transition of retinal pigment epithelium (RPE) cells. A failure of the current treatment (anti‐vascular endothelial growth factor therapy) has also been attributed to the progression of subretinal fibrosis. Hypoxia‐inducible factors (HIFs) increase gene expressions to promote fibrosis and neovascularization. HIFs act as a central pathway in the pathogenesis of AMD. HIF inhibitors may suppress ocular neovascularization. Nonetheless, further investigation is required to unravel the aspects of subretinal fibrosis. In this study, we used RPE‐specific HIFs or von Hippel–Lindau (VHL, a regulator of HIFs) conditional knockout (cKO) mice, along with pharmacological HIF inhibitors, to demonstrate the suppression of subretinal fibrosis. Fibrosis was suppressed by treatments of HIF inhibitors, and similar suppressive effects were detected in RPE‐specific Hif1a / Hif2a‐ and Hif1a ‐cKO mice. Promotive effects were observed in RPE‐specific Vhl ‐cKO mice, where fibrosis‐mediated pathologic processes were evident. Marine products' extracts and their component taurine suppressed fibrosis as HIF inhibitors. Our study shows critical roles of HIFs in the progression of fibrosis, linking them to the potential development of therapeutics for AMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrosisRetinal Pigment EpitheliumVon Hippel-Lindau Tumor Suppressor ProteinMice, KnockoutAnimalsMiceHypoxia-Inducible Factor 1, alpha SubunitBasic Helix-Loop-Helix ProteinsMacular DegenerationRetinaEpithelial-Mesenchymal TransitionMice, Inbred C57BLEndothelial PAS Domain-Containing Protein 1

Stichwörter der Autor:innen

age‐related macular degenerationchoroidal neovascularizationhypoxia‐inducible factorsmacular neovascularizationretinal pigment epitheliumsubretinal fibrosis

Substanzen

Von Hippel-Lindau Tumor Suppressor ProteinHypoxia-Inducible Factor 1, alpha SubunitBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1Hif1a protein, mouseVHL protein, mouse

Autor:innen und Institutionen

  • Laboratory of Photobiology, Keio University School of Medicine, Tokyo, Japan.
  • Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
  • Ophthalmology, Nihon University School of Medicine, Tokyo, Japan.
  • Aichi Animal Eye Clinic, Nagoya, Aichi, Japan.
  • Shizuoka Prefectural Research Institute of Fishery and Ocean, Shizuoka, Japan.
  • Marine Open Innovation Institute, Shizuoka, Japan.

ORCID-Profile: Deokho Lee, Yukihiro Miwa, Satoru Yamagami, Hiroyuki Nakashizuka, Hirokazu Kawagishi, Kazuno Negishi, Toshihide Kurihara

Förderung

  • KAKENHI
  • Development of Research Seeds Based on Marine Biotechnology from Shizuoka Prefecture
  • JST SPRING
  • AMED
  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development

Zitieren

APA

Shoda, C., Lee, D., Miwa, Y., Yamagami, S., Nakashizuka, H., Nimura, K., Okamoto, K., Kawagishi, H., Negishi, K., & Kurihara, T. (2024). Inhibition of hypoxia‐inducible factors suppresses subretinal fibrosis. The FASEB Journal, 38(13). https://doi.org/10.1096/fj.202400540rrr

Vancouver

Shoda C, Lee D, Miwa Y, Yamagami S, Nakashizuka H, Nimura K, et al. Inhibition of hypoxia‐inducible factors suppresses subretinal fibrosis. The FASEB Journal. 2024;38(13). doi:10.1096/fj.202400540rrr

BibTeX
@article{Shoda2024,
  author = {Shoda, Chiho and Lee, Deokho and Miwa, Yukihiro and Yamagami, Satoru and Nakashizuka, Hiroyuki and Nimura, Kazumi and Okamoto, Kazutoshi and Kawagishi, Hirokazu and Negishi, Kazuno and Kurihara, Toshihide},
  title = {Inhibition of hypoxia‐inducible factors suppresses subretinal fibrosis},
  journal = {The FASEB Journal},
  year = {2024},
  volume = {38},
  number = {13},
  doi = {10.1096/fj.202400540rrr}
}
Kostenlos starten →